Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2008
10/07/2008US7432047 Method for selective inactivation of viral replication
10/07/2008US7431936 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/07/2008US7431932 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition; reducing the risk of introducing or reintroducing neoplastic cells into the recipient
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008CA2451216C Sd1 gene involved in plant semidwarfing and uses thereof
10/07/2008CA2296067C Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
10/07/2008CA2259984C Precise efficacy assay methods for active agents including chemotherapeutic agents
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2209426C Human pak65
10/07/2008CA2173956C Dna encoding 1,3-beta-d glucan synthase subunits
10/07/2008CA2106061C Human follicle stimulating hormone receptor
10/02/2008WO2008119024A1 Modified antigen presenting cells and methods of use
10/02/2008WO2008118991A1 Methods and compositions for inducing apoptosis by stimulating er stress
10/02/2008WO2008118957A2 Methods for modulating embryonic stem cell differentiation
10/02/2008WO2008118926A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008WO2008118820A2 Somatic cell reprogramming
10/02/2008WO2008118587A2 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008WO2008118545A2 Methods for generating novel stabilized proteins
10/02/2008WO2008118493A1 Targeted neuronal and glial human embryonic stem cell line
10/02/2008WO2008118421A1 Human late stage motor neuron progenitor cells and methods of making and using same
10/02/2008WO2008118416A1 Carrier piece and method for preparing culture media
10/02/2008WO2008118410A2 Quantum dot labeled stem cells for use in providing pacemaker function
10/02/2008WO2008118020A1 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
10/02/2008WO2008117887A1 Plant of genus nicotiana with reduced content of carbonyls in combustion smoke and method for producing the same
10/02/2008WO2008117813A1 Chicken embryonic stem cell and method for evaluation thereof
10/02/2008WO2008117811A1 Transformant plant, transformed cell, protein production kit and method of producing protein
10/02/2008WO2008117561A1 Protein with sweet taste
10/02/2008WO2008117195A2 Use of microcarrier beads for detection and/or isolation of cells by flow cytometry
10/02/2008WO2008117026A1 Method for enhancing sperm survival
10/02/2008WO2008116889A1 A novel in vitro model of mature serosal-type mast cells for the analysis of autoimmune and allergic inflammation
10/02/2008WO2008116713A2 Apocrine cell line
10/02/2008WO2008116472A2 A method for introducing changes into a eukaryotic genome in vivo using hpv
10/02/2008WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008WO2008085962A3 Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
10/02/2008WO2008078056A3 Method for amplifying hcv in aedes mosquitoes
10/02/2008WO2008063771A3 Anti-cd20 antibodies and methods of use
10/02/2008WO2008062467A3 Cultured melanocytes on biopolymers
10/02/2008WO2008060362A3 Methods and compositions for the treatment of skin diseases and disorders
10/02/2008WO2008054517A3 Immunosuppressant binding antibodies and methods of obtaining and using same
10/02/2008WO2008048229A3 Stabilized lyophilized blood platelets
10/02/2008WO2008036437A3 Novel gene disruptions, compositions and methods relating thereto
10/02/2008WO2008025965A3 Retinoid compounds and their use
10/02/2008WO2008021140A3 Recombinant aav production in mammalian cells
10/02/2008WO2008011134A3 Use of late passage mesenchymal stem cells (mscs) for treatment of cardiac rhythm disorders
10/02/2008WO2008011133A3 Compositions of late passage mesenchymal stem cells (mscs)
10/02/2008WO2007124106A3 Application of antl-apoptotic genes in mammalian cells for perfusion culture.
10/02/2008WO2007120829A3 Methods for the cryopreservation of mammalian cells
10/02/2008WO2007117765A3 Ex vivo generated tissue system
10/02/2008WO2005072340A3 Novel polynucleotides encoding polypeptides and methods using same
10/02/2008US20080244791 Tuber preferential regulatory sequences for use in generating plants with enhanced nitrogen fixation and resistance to soil borne pathogens
10/02/2008US20080244790 Methyl-d-erythritol phosphate pathway genes
10/02/2008US20080244788 Wheat Cultivar 00WB80404
10/02/2008US20080244785 Cucumber Hybrid Paraiso
10/02/2008US20080244765 Methods and compositions for pollination disruption
10/02/2008US20080244762 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
10/02/2008US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
10/02/2008US20080242652 Indole derivatives and their metal conjugates and uses thereof
10/02/2008US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes
10/02/2008US20080242624 Cyclin D Polynucleotides, Polypeptides and Uses Thereof
10/02/2008US20080242613 Protease activated receptors; angiogenesis inhibitor; cardiovascular disorders
10/02/2008US20080242610 Anticarcinogenic agents; polypeptide including ligand that stimulants natural killer receptor and intracytoplasmic death domain
10/02/2008US20080242607 Glycosylation of peptides via o-linked glycosylation sequences
10/02/2008US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent
10/02/2008US20080242603 Interleukins; genetic engineering; vectors and host cells; anticancer agents; immunology diseases; infections; antiischemic agents; antitumor agents
10/02/2008US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization
10/02/2008US20080242599 Compositions and Methods for Increasing Osteoblast Cell Differentiation and Bone Generation
10/02/2008US20080242594 Contacting neuronal precursor cells with notch ligand and janus kinase and/or p38 inhibitor; isolated population of cells expressing nestin and STAT3 having phosphorylated serine 727
10/02/2008US20080242587 Including nucleotide sequence encoding Tie2 and vascular endothelial growth factor receptor (VEGF) components; edema and tumor growth prevention
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241927 Novel glyphosate-n-acetyltransferase (gat) genes
10/02/2008US20080241926 Using cytophilic polyelectrolyte multilayer for adhesion and propagation of hepatic cells
10/02/2008US20080241925 Adhering intercellularly attachment cell to substrate surface for use as template for replating; tissue culture; cell based bioassays
10/02/2008US20080241924 Using cell adhesion molecule specific immunoglobulin for prevention and treatment of colon, breast and cervical cancers
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241922 Use of Biocistronic DNA Constructs for Identifying Compounds that Inhibit IRES-Dependent Translation
10/02/2008US20080241921 Method of promoting differentiation of one or more human stem cells into human coronary endothelial cells on a synthetic tubular structure
10/02/2008US20080241920 Method of promoting differentiation of one or more human stem cells into human coronary endothelial cells on a synthetic tubular structure
10/02/2008US20080241919 Defined media for pluripotent stem cell culture
10/02/2008US20080241918 Hemagglutinin polypeptides, and reagents and methods relating thereto
10/02/2008US20080241906 Shifting elution properties of viral protein in order to enhanced purification from solution
10/02/2008US20080241905 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/02/2008US20080241903 Glycoproteins; modification methylases; derived from wild-type Methanococcus jannaschii
10/02/2008US20080241889 Expression vector for use in recombinational cloning
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241883 Enhanced nucleotide sequences for transfer and expression immunoglobulin fusions in cells
10/02/2008US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders
10/02/2008US20080241873 Multi-use multimodal imaging chelates
10/02/2008US20080241872 Using cold and menthol-sensitive receptor (CMR1) polypeptide as diagnostic tool in identifying modulators for treatment of pain and cold sensitivity
10/02/2008US20080241870 Culture of mesenchymal cells obtained from mammalian foetus of human origin, hematopoietic modulator capable of activating intracellular signaling, and culture medium; kits; leukemia
10/02/2008US20080241867 Expression vector comprising nucleotide sequences coding reporter protein/protease cleavage sequence fusion; detecting enzymatic activity in solution
10/02/2008US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241341 Expression vector for transforming soybean and controlled transcription of heterologous nucleotide sequences; animal feeds; nutraceuticals
10/02/2008US20080241340 Oil enhancing genes; diacylglycerol acyltransferase, phosphatidic acid phosphatase, and leucoanthocyanidin dioxygenase; transgenic seeds, cells, plants; feeds
10/02/2008US20080241268 Compositions and methods for wt1 specific immunotherapy
10/02/2008US20080241209 System and Method for Forming Bone, Ligament, and Bone-Ligament Constructs
10/02/2008US20080241207 Culture medium; antibodies; bioassays; drug screening; administering with an agonist or antagonist; stromal cells; implants
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage